Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Kagoya

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
International Immunology|August 17, 2023
Cytokine signaling in chimeric antigen receptor T-cell therapyYuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Strategies to overcome CAR-T cell exhaustion and terminal differentiation]Yuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[NF-κB activity in myeloid leukemia stem cells]Yuki Kagoya
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Molecular Profiles of Exhausted T Cells and Their Impact on Response to Immune Checkpoint Blockade]Yuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Development of next-generation chimeric antigen receptor-engineered T-cell therapy]Yuki Kagoya
Molecular Therapy. Oncology|May 25, 2026
Distinct roles of STAT3 and STAT5 in CAR T cell therapyYuki Kagoya
International Immunology|May 13, 2022
Dissecting the heterogeneity of exhausted T cells at the molecular levelYuki Kagoya
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[Enhancing CAR-T/CAR-NK Cells through by Cytokine Signaling]Yuki Kagoya
Cancer Science|August 24, 2022
Epigenetic engineering for optimal chimeric antigen receptor T cell therapyYusuke Ito, Yuki Kagoya
International Journal of Hematology|May 22, 2024
Current progress of CAR-T-cell therapy for patients with multiple myelomaTakahiro Nakashima, Yuki Kagoya
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
International Immunology|August 17, 2023
Cytokine signaling in chimeric antigen receptor T-cell therapyYuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Strategies to overcome CAR-T cell exhaustion and terminal differentiation]Yuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[NF-κB activity in myeloid leukemia stem cells]Yuki Kagoya
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Molecular Profiles of Exhausted T Cells and Their Impact on Response to Immune Checkpoint Blockade]Yuki Kagoya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Development of next-generation chimeric antigen receptor-engineered T-cell therapy]Yuki Kagoya
Molecular Therapy. Oncology|May 25, 2026
Distinct roles of STAT3 and STAT5 in CAR T cell therapyYuki Kagoya
International Immunology|May 13, 2022
Dissecting the heterogeneity of exhausted T cells at the molecular levelYuki Kagoya
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[Enhancing CAR-T/CAR-NK Cells through by Cytokine Signaling]Yuki Kagoya
Cancer Science|August 24, 2022
Epigenetic engineering for optimal chimeric antigen receptor T cell therapyYusuke Ito, Yuki Kagoya
International Journal of Hematology|May 22, 2024
Current progress of CAR-T-cell therapy for patients with multiple myelomaTakahiro Nakashima, Yuki Kagoya
Pageof 7